頭孢菌素劑的市全球場:趨勢，市場分析(2017 - 2022年)
Global Cephalosporin Drugs Market - Trends, Market Analysis - (2017 - 2022)
|出版商||Mordor Intelligence LLP||商品編碼||391378|
|出版日期||內容資訊||英文 205 Pages
|頭孢菌素劑的市全球場:趨勢，市場分析(2017 - 2022年) Global Cephalosporin Drugs Market - Trends, Market Analysis - (2017 - 2022)|
|出版日期: 2017年01月24日||內容資訊: 英文 205 Pages||
The Global Cephalosporin Drugs Market is estimated to be $ xx billion for the year 2015 to reach $ xx billion by the year 2020. The CAGR with which market is growing is anticipated to be x.x%.
The cephalosporins are a group of broad spectrum, semi-synthetic beta-lactam antibiotics derived from the group Cephalosporium. For few indications, cephalosporins are the preferred anti antibiotics. The key driver for the growth of this market is increasing research and development activities in many countries and the growing demand of anti-bacterials. The market is expected to experience uncertain regulatory reforms and spending high in research and development does not fetch the expected return of investment. It has also been observed that there is less drug development in pipeline for this category of anti-bacterials.
The global cephalosporin drugs market is segmented based on the spectrum of anti-microbial activity which includes first generation, second generation, third generation, fourth generation and fifth generation. The market is also segmented by the route of administration such as oral and injectables, by type such as branded and generics. The therapeutic segment of the market includes sexually transmitted infections, serious infections, respiratory tract infections, skin infections, urinary tract infections in pregnancy. The geographical regions considered include North America, Europe, Latin America, Middle East Asia and Asia Pacific. The clinical trial support services regulations differs from region to region.
The major companies in this market are Astellas, Lupin Pharmaceuticals, Bristol-Myers Squibb, Glaxo SmithKline, Roche, Ranbaxy, Merck, Pfizer, Sandoz,Teva Pharmaceuticals.
This report offers comprehensive profiles of these companies composed of their business strategy for biosimilars, financials, SWOT analysis, products and services and the insightful company analysis by our analyst.
What the report offers
Market Definition for the specified topic along with identification of key drivers and restraints for the market.
Market analysis for the Global Cephalosporin Drugs Market, with region specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.
Identification and analysis of the Macro and Micro factors that affect the Global Biosimilars market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.